Navigation Links


Corporation at Biology News

Corporation at Biology Products

Full-Configuration Camera Link NI PCIe-1429 from National Instruments Corporation

Description:The National Instruments PCIe-1429 is the industrys first PCI Express image acquisition board.With the NI PCIe-1429, you now can acquire images at the highest speeds, resolutions, and bit depths available for Camera Link cameras to perform demanding imaging applications such as synchronized data and image acquisition, fault analysis, and advanced motion tracking. In the past, acquiring ima...
Company:National Instruments Corporation

pMIR-mU6-Luc, Mouse U6 Luciferase Control Vector from Mirus Bio Corporation

Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference (RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can be synthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo. A convenient...
Company:Mirus Bio Corporation

pMIR-mU6, Mouse U6Template (Vector) from Mirus Bio Corporation

Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference(RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can besynthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo [1-4]. A conve...
Company:Mirus Bio Corporation

pMIR-hU6-Luc, Human U6 Luciferase Control Vector from Mirus Bio Corporation

Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference (RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can be synthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo. A convenient...
Company:Mirus Bio Corporation

LX80 Series Precision Stages from Parker Hannifin Corporation

Description:The LX80L is an extension of Parkers MX80 family of positioners, offering longer travel while maintaining a compact cross-section. LX80L bolt hole patterns mimic the MX80 family, allowing users to directly mount MX80 units and all accessory brackets to build multi-axis systems. Velocities to 3 m/s...
Company:Parker Hannifin Corporation

More>>

Corporation at Biology Technology

Trouble-shooting: Misincorporation or low fidelity

Here are some troubleshooting hints that we have gathered regarding misincorporation or low fidelity of PCR reactions: <a href="#Option1">Magne...

Roche Diagnostics Corporation

Advantages of Roche Applied Science amplification products <a href="http://w...

Roche Diagnostics Corporation

Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Ampl...

Promega Corporation: Wisconsin's quiet innovator

Quiet to those outside the life-science realm, that is. Inside the privately held company's suburban Madison walls, it's anything but silent, as a constant churn of innovation takes place. Thu...

Giuliani will keynote RedPrairie Corporation's user conference

Giuliani will discuss how leaders a...

More>>

Corporation at Medicine News

Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines

There is an increased Gold rush for Bird flu vaccines and drugs world wide with increased demand in United States.// Due to shortage of vaccines for bird flu vaccines the US has given contract to the Pharmaceutical Company Chiron Corporation to produce Bird flu vaccine. The contract is worth $62.5 million to produce the vaccines to encounter the demand. US Health Secretary Mike Leavitt s...
Corporation at Medicine Products
Corporation at Medicine Technology

Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

BLOOMFIELD, N.J., July 05, 2007 /PRNewswire/ -- AlfacellCorporation today announced that Lawrence A. Kenyon, executive vicepresident, chief financial officer and corporate secretary, willpresent an overview of the company's product development programsat 8 a.m. EDT on Thursday, July 12, 2007, at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference in New York. The aud...

Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron

BILLERICA, Massachusetts --- June20, 2007 --- Millipore Corporation today announced the release ofnew data concerning its ReNcell neural stem cell lines. Theresearch was conducted by the Department of Physiology atUniversity College London and ReNeuron Group plc, whose ReNcelldistribution agreement with Millipore was announced in 2006. The data will be presen...

NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis

ANN ARBOR, Mich., May 22, 2007 /PRNewswire/ -- NanoBioCorporation, a biopharmaceutical company developing novel productsfor the treatment and prevention of serious infections, todayannounced positive safety data from its Phase 1 clinical study ofNB-002, the company's drug candidate currently in a Phase 2clinical trial for the topical treatment of onychomycosis. The Phase 1 clinical...

Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease

Announces Plans for Advancing AT-1001 into Later Stage ClinicalTrials BALTIMORE, May 07, 2007 /PRNewswire/ -- Alba TherapeuticsCorporation today announced preliminary results from its Phase IIaclinical trial for AT-1001 in subjects with Celiac Disease (CD), anautoimmune disease affecting over 3 million people in the UnitedStates. Alba's study, the first Phase IIa trial in CD and the first...

EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting

Supports Local Mechanism of Action of NP-1 in Neuropathic Pain TARRYTOWN, N.Y., May 03, 2007 /PRNewswire-FirstCall/ -- EpiCeptCorporation announced today that it will present new data forEpiCept(TM) NP-1 on Thursday, May 3, 2007 at the 26th AnnualScientific Meeting of the American Pain Society in Washington D.C.EpiCept NP-1 is a patented topical cream formulation of twoFDA-approved drugs,...
Other TagsCalan
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
(Date:7/24/2008)... plants just as they do human athletes, but the pl... boost growth and development in plant cells is fa... A new study by plant biologists at the Carnegie I...led proteomics to identify key links in the steroi...ormones activate genes could lead not only to enha...
(Date:7/24/2008)...2008 Adult stem cells originate in a different pa...h proper stimulation they can produce new brain ce...study by UC Irvine scientists has shown. , Evide... mammalian brain are the ependymal cells that line...er than cells in the subventricular zone as biolog...
(Date:7/24/2008)... 24, 2008) A multi-institutional team of research...nesota Medical School, have developed a powerful t...method will allow researchers to generate syntheti...nces for inactivation or repair. , The potential ...rector of the Arnold and Mabel Beckman Center for ...
(Date:7/24/2008)...yphoon in Taiwan buries as much carbon in the ocea...ains in that country all year long combined. , ...dy published in a recent issue of the journal Geo...the chemistry of stream water and sediments that w...ppening at full force -- will help scientists deve...
Breaking Biology News(10 mins):Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3Adult stem cells activated in mammalian brain 2Adult stem cells activated in mammalian brain 3Consortium develops new method to manipulate genetic material 2Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Engaging 2008 Debate Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post Acute Care Delivery System 9555 1Engaging 2008 Debate Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post Acute Care Delivery System 9555 2Engaging 2008 Debate Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post Acute Care Delivery System 9555 3Engaging 2008 Debate Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post Acute Care Delivery System 9555 4Engaging 2008 Debate Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post Acute Care Delivery System 9555 5CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2594 1CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2594 2CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2594 3Anthera Announces Preliminary Positive Results From Once Daily A 002 Phase II Cardiovascular Trial 1202 1Anthera Announces Preliminary Positive Results From Once Daily A 002 Phase II Cardiovascular Trial 1202 2Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention 1197 1Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention 1197 2Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention 1197 3
Other Contentsnumbernumbernumbernumbernumbernumbernumbernumbernumbernumbercopycopycopycopycopycopycopycopycopycorkcorkcorollacoronarycoronarycoronarycoronarycoronarycoronarycoronaryluteumluteumluteumcorpuscorpuscorpuscorpuscorpuscortexcortexcortexcortexcortexcortexcortexcortex